RISK WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74% and 89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
RISK WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Trusted Trading Platform
Free account
Worldwide Trading
Portfolio Management
Grifols

Grifols SA 

Madrid-ibex

Grifols SA (GRFxmad) is a Spanish multinational pharmaceutical company headquartered in Barcelona, specializing in plasma-derived medicines and hospital pharmacy products. The company collects human blood plasma and manufactures plasma proteins including albumin, immunoglobulins, and clotting factors used to treat rare and chronic diseases. Grifols operates a global network of plasma donation centers, primarily in the United States. It is a constituent of the IBEX 35 index on Bolsa de Madrid and is also listed on Nasdaq. The company is one of the world's three largest plasma-derived medicine companies.

 GRF symbol info
 
 


 
Top stories by TradingView
 Technical analysis for GRF
 
GRF chart

Start trading
Grifols SA now

At In2Markets, we offer unique strategies designed to align with your goals and adapt to changing market conditions. Our team will provide you with real-time support and expert insights to answer your question in a quick and personal way. Whether you’re trading or managing your portfolio, we combine innovation with a personalized approach to ensure you stay ahead.

Update I2M Telefoon (1)